Automated External Defibrillator Market Analysis

Automated External Defibrillator Market Analysis

The market by product type is categorized into semi-automated external defibrillators and fully-automated external defibrillators. The semi-automated external defibrillator segment dominates the market with a revenue of around USD 741 million in 2023.
 

• The dominant market share of semi-automated external defibrillators (SAED) can be attributed to their intuitive interfaces, real-time guidance features, and suitability for diverse settings. These devices, designed for user-friendly operation and guided defibrillation processes, have gained prominence due to their effectiveness in enabling both trained and non-professional responders to deliver rapid and accurate defibrillation during emergency situations.  
  
   
• Moreover, the semi-automated features of SAEDs provide a level of oversight by allowing healthcare professionals to assess the patient's condition continually. This adaptability ensures that medical personnel can intervene or modify the defibrillation process as needed, fostering a more personalized and responsive approach to patient care. Due to such advantages, the segment is anticipated to grow over the forecast period.
   

The automated external defibrillator market by patient is categorized into adult and pediatric. The adult segment dominates the market with a revenue of around USD 1.1 billion in 2023.
 

• A major factor contributing to the dominance of automated external defibrillators (AEDs) for adult use is the notable increase in the geriatric population. The aging demographic profile worldwide has substantial implications for the prevalence and management of cardiac emergencies, thus shaping the landscape of AED usage.
   
• For instance, according to the Centers for Disease Control and Prevention data, in 2019, 10.9% of adults aged 45 years and older reported having coronary heart disease (CHD). Similarly, 7.1% of adults aged 45 to 64 years reported having CHD compared with 17.0% of adults aged 65 years and older. The geriatric population experiences a higher incidence of cardiac events, necessitating the availability of these cardiac rhythm management devices tailored to the specific physiological characteristics and heart rhythms observed in adults.
   
• Moreover, senior living facilities, including nursing homes and assisted living communities, strategically deploy adult AEDs due to the concentration of elderly residents. The presence of these devices addresses the immediate needs of seniors in the event of a cardiac emergency, aligning with the proactive healthcare approach in such settings, driving segment expansion.
   

The automated external defibrillator market by end-use is categorized into hospitals, prehospital care, homecare, and other end-users. The prehospital care segment held a significant market share in 2023 and is expected to register a CAGR of 7.5% over the analysis period.
 

• Cardiac emergencies, particularly instances of sudden cardiac arrest (SCA), demand immediate attention. Prehospital care, often provided by emergency medical services (EMS) and first responders, aims to deliver timely interventions, making AEDs a crucial component in prehospital cardiac care.
   
• Moreover, AEDs are strategically placed in ambulances and other first responder vehicles, ensuring that these life-saving devices are readily available at the scene of an emergency. The mobility of prehospital care units enables rapid deployment to various locations, addressing cardiac emergencies wherever they occur, hence, driving the growth of the market.
   

North America automated external defibrillator market accounted for USD 474.3 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The dominant share of North America in the global automated external defibrillators market is primarily attributed to several factors such as the presence of major industry players, surging prevalence of chronic heart diseases, supportive government initiatives, facilitative reimbursement scenario, and the presence of well-developed healthcare infrastructure. Additionally, the surge in private research funding for research and development of novel devices is propelling the regional market growth.
   
• Moreover, North America has an extensive patient population and well-established healthcare systems, including advanced cardiac care facilities, North America offers ready access to diagnosis, management, and treatment options for cardiac patients. The region is a hub for clinical research and trials in the field, further propelling the innovation of AED devices. Furthermore, stringent regulatory oversight and the availability of health insurance coverage ensure that AED devices adhere to high safety and efficacy standards while remaining accessible to patients, further fueling demand.